AI tools, scored for your job
Learn AI in 30 days
Overview Try It Reviews Why This Tool FAQ Pricing Top 10 Get Alerts News

Convexia — AI for Pharmaceutical & Biotech

Accelerate drug discovery by automating candidate screening and scientific evaluation.

DifferentiatorEnd-to-end AI stack replacing manual evaluations for early discovery.
ProofScans millions of global drug candidates to accelerate preclinical assessment.
Explore Convexia
Contact for pricing
7.5 Zekai
AI for Pharmaceutical & Biotech
Ease of Use
6.8
Accuracy
8.4
Value
7.0
Time Saving
7.6
Pharmaceutical R&D professionals can save an estimated 20-30% of their time on preliminary compound screening and evaluation.Saved / day
7.5/10Zekai Score
API Access
🏷 Is this your tool? Claim this listing →

Zekai Verdict

What is it?
Convexia offers an integrated AI solution for pharmaceutical R&D, automating drug diligence and candidate screening.
Best for
Drug Discovery Scientists and Preclinical Project Managers benefit most from Convexia, as it automates the initial…
Price
Pricing on request
Zekai Score
7.5/10
Hand-scored by Zekai

Top AI for Pharmaceutical & Biotech picks

See all 18 AI tools for Pharma →
⚡ Quick answer

For pharmaceutical and biotech R&D, Convexia is a leading AI solution for automating drug diligence and candidate screening. It replaces time-intensive manual evaluations with an end-to-end AI stack. This platform accelerates early discovery by scanning millions of global drug candidates, allowing expert resources to focus on advancing the most promising therapeutic assets.

CategoryAI for Pharmaceutical & Biotech
Best ForAutomating drug diligence and candidate screening.
Free
DifferentiatorEnd-to-end AI stack replacing manual evaluations for early discovery.
ProofScans millions of global drug candidates to accelerate preclinical assessment.
Rating7.5/10
📖 About Convexia
Prompt Templates

Try it with these prompts

Copy any prompt and paste it directly into the tool.

Discover Overlooked Drug Assets

Scan the globe for overlooked drug assets, from preclinical biotech to abandoned pharma IP. Our AI pulls structured and unstructured data to find high-potential candidates. Identify assets that traditional scouts might m…

Assess Drug Candidate Safety and Efficacy

Run deep in silico simulations using over 50 custom-tuned models to assess binding, toxicity, ADME/PK, immunogenicity, and mechanistic fit. Evaluate potential liabilities and predict absorption, distribution, metabolism,…

Evaluate Market and Operational Drug Risks

Uncover market signals like unmet need, competitive landscape, and IP positioning. Model operational risks using digital twin simulations to score execution risk before trials start, flagging trial fragility.

AI Prompts

Prompts for Pharma

Prompt 01 Summarize Target-Disease Association
Act as a molecular biologist. I am investigating [[DISEASE_NAME]], a [[DISEASE_TYPE]] disorder. My proposed target is [[PROTEIN_NAME]] (UniProt: [[UNIPROT_ID]]). Based on publicly available literature up to your last update, provide a conci…
Prompt 02 Generate a Target Dossier Brief
Act as a drug discovery project lead. Create a target dossier brief for [[GENE_SYMBOL]] in the context of [[THERAPEUTIC_AREA]]. The brief should be a maximum of 500 words and formatted for a slide presentation. Include the following section…
Prompt 03 Brainstorm Druggability Angles
My team is considering [[PROTEIN_TARGET]] for [[DISEASE]]. The protein is a [PROTEIN_CLASS, e.g., 'scaffolding protein with no known active site']. Acting as a panel of medicinal chemists and chemical biologists, brainstorm three distinct s…
See all 15 AI prompts for Pharma →
Social Proof

Trusted by professionals

Ease of Use
6.8
Accuracy
8.4
Value
7.0
Time Saving
7.6

"Convexia has revolutionized our early discovery phase. The ability to quickly scan and assess millions of compounds against critical parameters has drastically reduced our time to identify promising leads. It's an indispensable tool for any serious R&D team."

Dr. Emily Carter, Lead Scientist — Biotechnology Company

"The automated scientific evaluation stack provides valuable, data-driven insights that help us de-risk our pipeline early. While we had to consult sales for pricing, the potential efficiency gains are substantial for our preclinical assessments."

Mark Johnson, Preclinical Project Manager — Pharmaceutical Firm

"Convexia's AI efficiently handles the heavy lifting of sifting through vast compound libraries. Its accuracy in predicting binding affinity and ADME/PK profiles allows my team to focus our experimental efforts more strategically, accelerating our R&D timelines."

Dr. Anya Sharma, Computational Chemist — Drug Discovery Startup

"Replacing manual diligence with Convexia's AI stack is a game-changer for our pipeline efficiency. We're still exploring its full integration capabilities, but the core functionality for accelerating early discovery is exceptionally strong."

Ben Davis, R&D Director — Pharmaceutical Research Institute
Comparison

Best Convexia alternatives

Convexia vs BenevolentAI: Convexia focuses specifically on automating drug diligence and candidate screening with an end-to-end AI stack. This makes it ideal for teams looking to accelerate early discovery and preclinical assessment by replacing manual evaluations. In contrast, BenevolentAI offers a broader, more comprehensive platform that spans the entire drug discovery and development process, from target identification to clinical trial design. While BenevolentAI provides a wider scope, Convexia’s specialized approach offers a targeted solution for organizations aiming to optimize the efficiency of their initial R&D phases, rapidly filtering through millions of potential therapeutic assets.

The decision

Is Convexia worth it?

Return on investment
By automating time-intensive drug diligence, Convexia enables a single research scientist to evaluate the output of what would typically require a small team, redirecting expert resources toward higher-value strategic tasks.
Built for
Pharmaceutical R&D professionals, including medicinal chemists, toxicologists, and project managers at biotech and large pharmaceutical companies.
Compliance
Compliance posture not publicly documented — verify with vendor.
Who It's For

Why Pharmaceutical & Biotech choose this tool

🎯
Built for
Drug Discovery Scientists and Preclinical Project Managers benefit most from Convexia, as it automates the initial, labor-intensive stages of identifying and evaluating potential drug candidates, significantly speeding up the transition from concept to viable lead compounds.
In-Depth Overview

Convexia directly addresses the time-intensive nature of drug diligence in pharmaceutical R&D. Its AI-driven automation of candidate scanning and scientific evaluation frees up expert resources, enabling faster progression of promising therapeutic assets.

Key Use Cases

🎯
A Drug Discovery Scientist uses Convexia to rapidly screen novel compounds for potential therapeutic targets
📋
A Preclinical Project Manager uses Convexia to assess ADME/PK profiles of lead candidates
🔗
💡
A Computational Chemist uses Convexia to evaluate binding affinity and toxicity predictions
🚀
✓ Pros
• Streamlines early discovery and preclinical assessment by scanning millions of global drug candidates, saving valuable research time.
• Empowers R&D teams to focus expertise on promising compounds by automating preliminary screening, enhancing pipeline efficiency.
• Provides data-driven insights into critical drug properties like binding affinity, toxicity, and ADME/PK profiles through a sophisticated scientific evaluation stack.
· Cons
• Pricing is not publicly available and requires direct contact with sales.
• Specific integration partners are not detailed, requiring further inquiry.
Questions & Answers

Frequently asked questions

Does Convexia offer a free trial?

+
Pricing and trial availability require direct contact with the Convexia sales team.

What is the best use of Convexia for Pharmaceutical R&D professionals?

+
Convexia is best utilized for accelerating early-stage drug discovery and preclinical assessment by automating the screening of millions of drug candidates and evaluating critical scientific properties.

What integrations does Convexia offer?

+
Specific integration details are not publicly disclosed and would need to be confirmed with the Convexia sales team.

How does Convexia provide value for money in Pharmaceutical R&D?

+
Convexia offers value by significantly reducing the time and resources spent on manual data analysis and preliminary compound screening, allowing R&D teams to focus on more promising assets and expedite pipeline progression.
Plans & Pricing

Convexia pricing and plans

Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.

See all 18 AI tools for Pharma →
Free guide

Take it with you

Convexia Quick Start Guide
  • What is Convexia?
  • How it accelerates drug diligence.
  • Integrating with your R&D workflow.
  • Defining screening parameters.
  • Inputting therapeutic targets.
+5 more steps inside the guide
Send me the full guide

Get Convexia deal alerts

Be the first to know when Convexia drops a new discount, adds features, or changes pricing.

Exclusive Convexia discount codes
New feature announcements
Best alternative picks when pricing changes
Zero spam — unsubscribe anytime
🎉
You're subscribed!
We'll notify you when Convexia has a new deal.
AI Directory

About Convexia

Full Description

Convexia offers an integrated AI solution for pharmaceutical R&D, automating drug diligence and candidate screening. It supports professionals advancing therapeutic assets by replacing manual evaluations with an end-to-end AI stack. This platform accelerates early discovery and preclinical assessment by scanning millions of global drug candidates.

Disclaimer
Zekai is an independent AI tools directory. We are not affiliated with, endorsed by, or officially connected to Convexia unless clearly stated. All product names, logos, and brands are the property of their respective owners and are used for identification purposes only. The information on this page — including pricing, features, and availability — is general information, may have changed since our last review, and is not professional advice. Zekai Scores and verdicts are our editorial opinion. Some outbound links are affiliate links that may earn us a commission at no extra cost to you. Spotted outdated or incorrect information? Request a correction →
Previous Tool Blank Bio
All AI Tools A–Z →
Visit website ↗
Convexia7.5Try Convexia ↗Next tool →
Today's top 3 AI for Pharmaceutical & Biotech tools →

See Zekai first in Google